Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v2-EN
Language French English
Date Updated 2022-11-15 2022-10-05
Drug Identification Number 02452456 02452456
Brand name BORTEZOMIB FOR INJECTION BORTEZOMIB FOR INJECTION
Common or Proper name Bortezomib Bortezomib
Company Name DR REDDY'S LABORATORIES LTD DR REDDY'S LABORATORIES LTD
Ingredients BORTEZOMIB BORTEZOMIB
Strength(s) 3.5MG 3.5MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size vial vial
ATC code L01XG L01XG
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-10-30 2022-10-30
Actual start date
Estimated end date 2022-11-14 2022-11-14
Actual end date 2022-11-14
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments N/A N/A
Health Canada comments